Could moving the wrong arm ease nerve pain? new study investigates
NCT ID NCT07248943
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a gentle, hands-on movement technique applied to the non-painful side can reduce pain and disability in people with cervical radiculopathy (nerve pain in the neck and arm). It includes 40 adults who will receive a single session of this technique. The goal is to see if this approach works for those who cannot tolerate direct treatment of their painful arm.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Contralateral neural tissue mobilization (a gentle, hands-on movement technique applied to the non-painful side)
- What this could lead to
- If it works, this could offer a pain-relief option for people with cervical radiculopathy who cannot tolerate direct treatment of their painful arm.
- What could go wrong
- This is a very small, early exploratory study with only 40 participants and no control group. Results may not apply to everyone, and the effect may be small or temporary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL RADICULOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tape to tame Post-Surgery face swelling?
- Electric pulses on the wrist may tame colonoscopy pain
- Virtual reality may distract patients from pain and fear during anesthesia
- Could a gentle yoga practice turn down the Body's pain and inflammation?
- Can a 5-Pill opioid prescription match a 30-Pill one after hip surgery?
- Parkinson's pain: could a new Add-On drug bring relief?